Cardinal Health, Inc. CAH
- Market cap
- $51.6B
- P/E
- 30.3×
Follow CAH
Cardinal Health, Inc. (CAH) EV/Sales
As of 25 September 2026, Cardinal Health, Inc. (CAH) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (July 2022) to 0.3× (March 2015); the current reading is higher than 75% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 0.2× | 16.57% |
| FY2025 | 0.2× | 92.41% |
| FY2024 | 0.1× | (14.66%) |
| FY2023 | 0.1× | 47.55% |
| FY2022 | 0.1× | (30.25%) |
| FY2021 | 0.1× | (4.91%) |
| FY2020 | 0.1× | (7.07%) |
| FY2019 | 0.1× | (17.90%) |
| FY2018 | 0.2× | (23.81%) |
| FY2017 | 0.2× | (8.05%) |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.2× | 8.49% |
| Mar 2026 | 0.2× | (2.64%) |
| Dec 2025 | 0.2× | 25.45% |
| Sep 2025 | 0.2× | (12.03%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| COR Cencora, Inc. compare | 0.2× |
| CAH Cardinal Health, Inc. | 0.2× |
| MCK McKesson Corporation compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.4× |
| ACH Accendra Health, Inc. compare | 0.9× |
| HSIC Henry Schein, Inc. compare | 0.9× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| FOCL FocalTherics compare | 2.4× |
| Medical Distribution industry median | 0.6× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on CAH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement